This Major Cannabis Ruling is Already Seeing Significant International Coverage

Mexico could be one of the biggest players in the North American cannabis market, according to Xebra Brands (CSE:XBRA)(OTC:XBRAF), the first company allowed to commercialize cannabis per a Mexican Supreme Court ruling. Even better, according to Xebra Brands President Robert Giustra, as quoted by Reuters, “Mexico is clearly legalizing. It's going to happen, probably next year.” Once that happens, Mexico could become one of the biggest cannabis markets in the world, and could secure a big piece of an estimated $73.6 billion global market, as estimated by Grand View Research. In addition to Xebra Brands, the news could be a major catalyst for Aurora Cannabis (NASDAQ:ACB)(TSX:ACB), Canopy Growth (TSX:WEED)(NASDAQ:CGC), Tilray Inc. (NASDAQ:TLRY)(TSX:TLRY), and OrganiGram Holdings (NASDAQ:OGI)(TSX:OGI).

Even more exciting, “Xebra is moving quickly to take advantage of its absolute first mover advantage. Discussions are underway to secure up to 300 hectares of suitable land for cultivation, and multiple Canadian and American companies with cannabis processing and extraction expertise have expressed an interest in partnering in Mexico. Manufacturing joint-venture opportunities with established Mexican parties have been identified, and distribution channels are being explored,” as noted in a company press release.

Xebra Seeing International Tier 1 Press Coverage in Wake of Mexican Supreme Court Decision

Xebra Brands Ltd. a cannabis company, reports that it has received significant news coverage by Mexican and international Tier 1 media, since the December 2ndannouncement that it has received an injunction from the Mexican Supreme Court, granting it an outright first-mover advantage in the Mexican CBD and CBG industry.

The international media coverage includes interviews with Xebra’s Chairman Robert Giustra and CNN en ESPAÑOL, Reuters and the Wall Street Journal (unpublished). The CNN interview aired on December 18, 2021 in the United States, Latin America and the Caribbean. The Reuters interview was published on December 17, 2021, and was also published by Forbes, among other noteworthy media outlets. In Mexico, Xebra received widespread coverage by all major media covered Xebra’s injunction news, including the top newspapers in politics, economy and finance, as well as Mexico’s largest television broadcaster.

The significance and value of Xebra’s Mexican injunction is just beginning to be understood by the global cannabis industry. Xebra believes its first-mover-advantage in Mexico could last 1 to 3 years, and that it can potentially disrupt the U.S. and Canadian CBD and CBG market, as cultivation and product manufacturing moves south to take advantage of more favorable costing, ideal climate, and the USMCA free trade agreement. In addition, the Mexican cannabis consumer market is expected to be lucrative.

Dozens of published articles can be found online, however following are links to selective recent media coverage on Xebra:

INTERNATIONAL COVERAGE

REUTERS

Canada's Xebra Brands Bets on Mexico as Future Leader of Industrial Pot Production.

https://www.reuters.com/world/americas/canadas-xebra-brands-bets-mexico-future-leader-industrial-pot-production-2021-12-17/

Also published by: Forbes, USNEWS, Yahoo! News, INFOBAE, La Nación, MSN Noticias, EXPANSIÓN, El Economista, and El Imparcial.

BLOOMBERG

Xebra Is an Absolute Cannabis First Mover in Mexico with Supreme Court Decision Granting It an Injunction.

https://www.bloomberg.com/press-releases/2021-12-02/xebra-is-an-absolute-cannabis-first-mover-in-mexico-with-supreme-court-decision-granting-it-an-injunction-kwp2xhfx

CNN en ESPAÑOL - “Mercado México” (in Spanish)

Interview to Robert Giustra, Chairman of the Board, Xebra Brands Ltd.

Can be located at https://cnnespanol.cnn.com/

FINANCIAL POST

This Company Is the One And Only Authorized To Commercialize CBD and CBG in Mexico.

https://financialpost.com/business-trends/this-company-is-the-one-and-only-authorized-to-commercialize-cbd-and-cbg-in-mexico

MARKET WATCH

Mexico’s Supreme Court Ruling Just Gave This Cannabis Company First Mover Advantage.

https://www.marketwatch.com/press-release/mexicos-supreme-court-ruling-just-gave-this-cannabis-company-first-mover-advantage-2021-12-03-91972739

MEXICAN MEDIA COVERAGE

REFORMA (Mexico´s most popular newspaper) (in Spanish).

Autoriza Corte cannabis para usos industriales.

“Mexican Supreme Court Rules in Favor of Cannabis for Industrial Use”.

https://www.reforma.com/autoriza-corte-cannabis-para-usos-industriales/ar2307521

EL UNIVERSAL (Mexico´s second most popular newspaper)(in Spanish).

Otro amparo en favor de la legalización del cannabis.

“Another Injunction, Now for Industrial Purposes, Granted In Favor of Cannabis Legalization”.

https://www.eluniversal.com.mx/opinion/guillermo-nieto/otro-amparo-en-favor-de-la-legalizacion-del-cannabis

EL FINANCIERO BLOMBERG (in Spanish).

SCJN declaró inconstitucional la prohibición para siembra, cultivo y cosecha de cannabis con fines industriales.

“Supreme Court Declares Unconstitutional the Prohibition of Cannabis for Industrial Use”.

https://www.efinf.com/clipviewer/files/8a1c0cf8528729043900db82b590f654.mp4

NOTICIEROS TELEVISA (Mexico’s largest broadcaster) (in Spanish).

SCJN autoriza por primera vez la siembra de cannabis con fines industriales.

“Supreme Court Rules for the First Time in Favor of Cannabis for Industrial Purposes”.

https://noticieros.televisa.com/ultimas-noticias/cjn-autoriza-primera-vez-siembra-cannabis-fines-industriales/

GRUPO IMAGEN (Radio station with the 3rd largest audience in Mexico) (in Spanish)

Entrevista con, Rodrigo Gallardo, director general de Desart MX en 90.5 Imagen, Negocios en Imagen y Excelsior Tv con Darío Celis Estrada y Rogelio Varela.

“Interview with Xebra Brands president, Rodrigo Gallardo”.

https://www.youtube.com/watch?v=ODmgn1KIe3A

OVACIONES (Front page in Mexican national newspaper) (in Spanish).

Autoriza la Corte cannabis para uso industrial.

“Supreme Court Rules in Favor of Cannabis for Industrial Purposes”.

https://www.efinf.com/clipviewer/files/7f83e4e12f0434a69b1007e1d2a00e69.pdf

EXPANSION (Most important business magazine in Mexico)(in Spanish).

Ventas de cannabis valdrán 102,000 mdd en 2026, México define liderazgo en 2022.

“Sales of Cannabis expected to reach USD$102 million, First Movers Position Themselves in 2022”.

https://expansion.mx/economia/2021/12/18/ventas-mundial-cannabis-105-mmdd-2026-mexico-lider-2022?utm_source=dlvr.it&utm_medium=twitter

Other related developments from around the markets include:

Aurora Cannabis, together with 22nd Century Group, Inc.announced a three-way non-exclusive agreement to license biosynthesis intellectual property to Cronos Group Inc., intended to assist in the advancement of research and development on the biosynthesis of cannabinoids. Biosynthesis, a process common in the pharmaceutical industry, involves using living micro-organisms to convert simple substances into complex compounds. Through biosynthesis, cannabinoids, particularly those that are rare such as cannabigerol (CBG), cannabichromene (CBC) and cannabinol (CBN), are expected to be produced efficiently and reliably at high levels of purity.

Canopy Growth has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH, to Dermapharm Holding SE, a European pharmaceutical company headquartered in Grünwald, Germany. The C³ business develops and manufactures pharmaceutical products and is comprised of Spectrum Therapeutics GmbH, based in Neumarkt-in-der-Oberpfalz, Germany, THC Pharm GmbH The Health Concept, based in Frankfurt, Germany, and Spectrum Therapeutics Austria GmbH, based in Vienna, Austria.

Tilray Inc., a global pioneer in cannabis research, cultivation, production, and distribution, announced that its medical subsidiary, Aphria, has launched medical cannabis oral strips in THC and CBD-rich varieties. Powered by QuickStrip’s™ proprietary technology, each Aphria medical strip contains a thin, edible film that contains rapidly dissolving, micronized cannabinoids that absorb directly into the bloodstream, providing patients with a fast-acting, convenient, and precise dosing experience for relief from a range of conditions. Irwin D. Simon, Tilray’s Chairman and Chief Executive Officer, said, “Tilray’s medical brands, Aphria, Symbios, and Tilray, are relentlessly committed to investing in patient wellness through a portfolio of new innovative product offerings, GMP-certified cultivation, and the earned trust of the medical community. The launch of the Aphria-branded medical strips is a compelling proof point in this regard, and, given the growing expansion of medical cannabis across the globe, we believe we are exceptionally well-positioned in this high-growth, high-margin market moving forward. We look forward to extending our leadership in medical cannabis and to delivering value for patients and shareholders alike.”

OrganiGram Holdings, a leading licensed producer of cannabis, announced its results for the fourth quarter ended August 31, 2021. “The results in Q4 Fiscal 2021 demonstrate the momentum we have achieved from our efforts to lead innovation and increase efficiencies. In the quarter, we introduced exciting new products that were embraced by consumers and we achieved higher crop yields at a lower cost” said Beena Goldenberg, Chief Executive Officer. “We are particularly pleased with our market share gains in the quarter to become a #4 LP and will build on these successes into Fiscal 2022.”

Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Xebra Brands has paid three thousand five hundred dollars for advertising and marketing services to be distributed by Winning Media. Winning Media is only compensated for its services in the form of cash-based compensation. Winning Media owns ZERO shares of Xebra Brands. Click here for disclaimer.

Contact Information:
2818047972
[email protected]